Alzheimer's is one of the most common neurodegenerative diseases, robbing those affected of their independence, cherished memories, and, ultimately, their lives. Since its inception in 2011, the Nantz National Alzheimer Center (NNAC) has become a world-renowned research and referral center, treating thousands of patients each year. Its goals: prevent Alzheimer’s disease, slow memory loss progression and improve the quality of life for every patient. 

The NNAC provides an environment of comprehensive, compassionate care for patients and their families. The center's interdisciplinary team thoroughly evaluates each patient to ensure all reversible medical conditions causing memory loss, including hydrocephalus, vascular disease and sleep disorders, are diagnosed and treated. This approach has resulted in dramatic improvements in quality of life for many patients. 

Research to Discover New Treatments

To give hope to patients with Alzheimer’s disease and other frequent causes of memory loss, the NNAC is vigorously pursuing research to discover new treatments. Excelling in the use of clinical and research imaging biomarkers, the NNAC has contributed important scientific information relevant to treatment. Multiple preclinical and clinical studies are proceeding to evaluate various approaches and new medications aimed at delaying the progression of the disease or stopping its course.

Key discoveries in the NNAC include:

• Abnormal  tau propagates through brain networks
• Abnormal tau more closely associated with neurodegeneration than amyloid plaque
• “Off-target” binding of tau tracer explained by regional permeability